Published on in Vol 10 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/53170, first published .
Mediating Effect of Tobacco Dependence on the Association Between Maternal Smoking During Pregnancy and Chronic Obstructive Pulmonary Disease: Case-Control Study

Mediating Effect of Tobacco Dependence on the Association Between Maternal Smoking During Pregnancy and Chronic Obstructive Pulmonary Disease: Case-Control Study

Mediating Effect of Tobacco Dependence on the Association Between Maternal Smoking During Pregnancy and Chronic Obstructive Pulmonary Disease: Case-Control Study

Original Paper

1China-Japan Friendship School of Clinical Medicine, Capital Medical University, Beijing, China

2National Center for Respiratory Medicine, Beijing, China

3State Key Laboratory of Respiratory Health and Multimorbidity, Beijing, China

4National Clinical Research Center for Respiratory Diseases, Beijing, China

5Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China

6Department of Tobacco Control and Prevention of Respiratory Diseases, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China

7WHO Collaborating Centre for Tobacco Cessation and Respiratory Diseases Prevention, Beijing, China

8Department of Pulmonary and Critical Care Medicine, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Taiyuan, China

9Department of Pulmonary and Critical Care Medicine, First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China

10Department of Pulmonary and Critical Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

11Department of Pulmonary and Critical Care Medicine, Guizhou Provincial People’s Hospital, Guiyang, China

12Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China

13Department of Pulmonary and Critical Care Medicine, First Hospital of China Medical University, Shenyang, China

14State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Diseases, Guangzhou Institute of Respiratory Diseases, First Affiliated Hospital, Guangzhou Medical University, Guangzhou, China

15Department of Pulmonary and Critical Care Medicine, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China

16State Key Laboratory of Biotherapy of China and Department of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, China

17Beijing Key Laboratory of Respiratory and Pulmonary Circulation Disorders, Department of Pulmonary and Critical Care Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China

18Department of Pulmonary and Critical Care Medicine, Peking University Third Hospital, Beijing, China

19Department of Respiratory and Critical Care Medicine, Beijing Hospital, Beijing, China

20National Center of Gerontology, Beijing, China

21Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine, Peking Union Medical College, Beijing, China

22Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China

23Center for Clinical Epidemiology and Evidence-Based Medicine, Beijing Children's Hospital, Capital Medical University, Beijing, China

24National Center for Children’s Health, Beijing, China

25Department of Stomatology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China

26Department of Epidemiology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China

27Beijing Institute of Respiratory Medicine, Beijing, China

28National Heart and Lung Institute, Imperial College London and Royal Brompton and Harefield NHS Trust, London, United Kingdom

29Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom

30Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA, United States

31Data and Project Management Unit, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China

32See Acknowledgements

*these authors contributed equally

Corresponding Author:

Dan Xiao, MD

Department of Tobacco Control and Prevention of Respiratory Diseases

Center of Respiratory Medicine

China-Japan Friendship Hospital

Yinghua Street

Beijing, 100029

China

Phone: 86 010 8420 5425

Email: danxiao@263.net


Background: Maternal smoking during pregnancy (MSDP) is a known risk factor for offspring developing chronic obstructive pulmonary disease (COPD), but the underlying mechanism remains unclear.

Objective: This study aimed to explore whether the increased COPD risk associated with MSDP could be attributed to tobacco dependence (TD).

Methods: This case-control study used data from the nationwide cross-sectional China Pulmonary Health study, with controls matched for age, sex, and smoking status. TD was defined as smoking within 30 minutes of waking, and the severity of TD was assessed using the Fagerstrom Test for Nicotine Dependence. COPD was diagnosed when the ratio of forced expiratory volume in 1 second to forced vital capacity was <0.7 in a postbronchodilator pulmonary function test according to the 2017 Global Initiative for Chronic Obstructive Lung Disease criteria. Logistic regression was used to examine the correlation between MSDP and COPD, adjusting for age, sex, BMI, educational attainment, place of residence, ethnic background, occupation, childhood passive smoking, residential fine particulate matter, history of childhood pneumonia or bronchitis, average annual household income, and medical history (coronary heart disease, hypertension, and diabetes). Mediation analysis examined TD as a potential mediator in the link between MSDP and COPD risk. The significance of the indirect effect was assessed through 1000 iterations of the “bootstrap” method.

Results: The study included 5943 participants (2991 with COPD and 2952 controls). Mothers of the COPD group had higher pregnancy smoking rates (COPD: n=305, 10.20%; controls: n=211, 7.10%; P<.001). TD was more prevalent in the COPD group (COPD: n=582, 40.40%; controls: n=478, 33.90%; P<.001). After adjusting for covariates, MSDP had a significant effect on COPD (β=.097; P<.001). There was an association between MSDP and TD (β=.074; P<.001) as well as between TD and COPD (β=.048; P=.007). Mediation analysis of TD in the MSDP-COPD association showed significant direct and indirect effects (direct: β=.094; P<.001 and indirect: β=.004; P=.03). The indirect effect remains present in the smoking population (direct: β=.120; P<.001 and indirect: β=.002; P=.03).

Conclusions: This study highlighted the potential association between MSDP and the risk of COPD in offspring, revealing the mediating role of TD in this association. These findings contribute to a deeper understanding of the impact of prenatal tobacco exposure on lung health, laying the groundwork for the development of relevant prevention and treatment strategies.

JMIR Public Health Surveill 2024;10:e53170

doi:10.2196/53170

Keywords



Chronic obstructive pulmonary disease (COPD) is a global health challenge, ranking among the leading causes of both morbidity and mortality worldwide [1]. It was estimated that COPD affected a substantial portion of the global population with a prevalence rate of 10.3% among individuals, and the number of individuals afflicted with COPD has been on the rise [2]. Notably, China accounts for nearly a quarter of global COPD cases, with a 67% increase in prevalence among individuals aged 40 years and older between 2012 and 2015 [3].

COPD is influenced by various factors, including genetics, lifestyle, environmental factors, and other influencing factors [2-5]. Smoking, recognized as the most significant cause of COPD, leads to its development in approximately half of all smokers [6,7]. The prenatal and perinatal phases are crucial for lung development, with maternal smoking linked to offspring susceptibility to various health issues [8-10]. A systematic review suggested that maternal smoking during pregnancy (MSDP) is associated with an increased risk of COPD [11]. MSDP may directly impact fetal development, influencing the formation of the central nervous system and respiratory system [12]. Given the vulnerability of embryos and fetuses to the external environment, maternal smoking may exert a more pronounced effect on fetal development [13].

Despite widespread recognition of the adverse effects of MSDP on offspring COPD [11], the underlying mechanisms remain incompletely elucidated. Tobacco dependence (TD) is a complex condition influenced by genetic and environmental factors, classified as a mental disorder according to the International Classification of Diseases, and TD should be recognized as a lethal noncommunicable disease [14]. Previous studies have identified TD as an independent risk factor for atherosclerosis [15]. Notably, TD is prevalent among smokers, often associated with heightened smoking intensity and lower cessation rates [16], and approximately 40% of smokers experience impaired lung function and develop COPD [17]. A meta-analysis indicates an elevated risk of smoking and TD in offspring associated with MSDP [18]. Given these associations, our hypothesis posits that TD plays a pivotal mediating role in the association between MSDP and COPD.

Therefore, this study aims to investigate whether TD serves as a mediator in the association between MSDP and the risk of COPD in offspring. To achieve this, we used data from the national cross-sectional China Pulmonary Health (CPH) study [3] and conducted a case-control study to explore the role of TD in the association between MSDP and COPD. The findings will contribute to the development of targeted interventions focused on TD.


Participants and Study Design

The study population was drawn from the national cross-sectional CPH study [3,19,20], the largest study assessing the burden of COPD in China. The CPH study, encompassing a vast nationwide cross-sectional examination, encompassed 57,779 Chinese adults aged 20 years and older across 10 provinces in China. This extensive study incorporated 80 urban and 80 rural areas, using a multistage stratified cluster sampling approach, The details of recruitment for the CPH can be found elsewhere [3]. Trained health workers in local community health centers administered standardized questionnaire surveys to all participants, capturing essential information on sociodemographic status, medical history, lifestyle, and more. The questionnaire information involved in this study can be obtained in Table S1 in Multimedia Appendix 1.

In this study, a case-control design was used, and the workflow is illustrated in Figure 1. Inclusion criteria for the case group were as follows: (1) provision of signed informed consent, (2) age of 18 years or older, and (3) availability of complete questionnaire information. Individuals with other conditions such as asthma, tuberculosis, lung cancer, lung inflammation, and missing information were excluded. Control participants were matched for age, sex, and smoking from cohort. The matching tolerance can be found in Table S2 in Multimedia Appendix 1. Ultimately, a total of 2991 patients in the COPD group and 2952 controls were included in this study.

Figure 1. The workflow of study. COPD: chronic obstructive pulmonary disease; FTND: Fagerstrom Test for Nicotine Dependence.

Definition of MSDP and Evaluation of TD

MSDP was self-reported through a questionnaire, with all participants asked to respond to the question, “Did your mother smoke during pregnancy? (yes or no).” Upon awakening, smoking within the first 30 minutes was defined as indicative of TD, based on prior study [21]. The severity of TD was assessed using the Fagerstrom Test for Nicotine Dependence (FTND) [22]. FTND is a standardized tool for evaluating the degree of physical nicotine addiction. It consists of six items: (1) How soon after waking do you smoke your first cigarette (within 5 minutes, 6 to 30 minutes, 31 to 60 minutes, and after 60 minutes)? (2) Do you find it difficult to refrain from smoking in places where it is prohibited (yes or no)? (3) Which cigarette would you find most difficult to give up (the first one in the morning or any other)? (4) How many cigarettes do you smoke per day (10 or less, 11 to 20, 21 to 30, and 31 or more)? (5) Do you smoke more frequently during the first hour after waking compared to the rest of the day (yes or no)? and (6) Do you smoke when you are so ill that you are confined to bed most of the day (yes or no)? The FTND generates a total score ranging from 0 to 10, with scores calculated as the sum of individual items. Yes or no items are scored as 0 or 1, and multiple-choice items are scored as 0 to 3. The questionnaire provided a comprehensive assessment of cigarette consumption, compulsion, and dependence. A higher total FTND score indicates a greater degree of TD. All participants reported their smoking status (yes or no). Smoking was defined as having consumed 100 cigarettes in one’s lifetime, encompassing both current and former smokers.

To address potential recall bias in self-reported MSDP, we implemented rigorous quality control measures. Our questionnaire design emphasized clarity and comprehensibility, and interviewers received detailed training to ensure precise definitions of smoking behavior. Memory aids were provided to aid accurate recall, and privacy protection measures were emphasized to minimize bias.

Definition of COPD

All study participants underwent postbronchodilator pulmonary function tests, including measurements of forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC) and FEV1/FVC ratio. COPD was diagnosed in accordance with the criteria set forth by the 2017 Global Initiative for Chronic Obstructive Lung Disease [23] if the participant’s FEV1/FVC ratio was <0.7.

Covariates

This study incorporated several covariates, including age (years), sex (male or female), BMI (calculated as weight in kilograms divided by the square of height in meters), educational attainment (primary and below, junior middle school, senior high school, or bachelor and above), place of residence (urban or rural), ethnic background (Han Chinese or other), occupation (farmer, worker, or other), childhood passive smoking, residential fine particulate matter (PM2.5) exposure, history of childhood pneumonia or bronchitis (yes or no), average annual household income, and medical history (coronary heart disease, hypertension, and diabetes).

Statistical Analysis

For normally distributed continuous variables, descriptive statistics are presented as mean (SD). Categorical variables are expressed as numbers and percentages. The Kolmogorov-Smirnov test was used to assess the normality of continuous variables. Comparisons of continuous variables were conducted using the Mann-Whitney U test, while categorical variables were compared using the chi-square test.

Mediation analysis, as outlined by Baron and Kenny [24], was used to investigate the potential mediating role of TD in the association between MSDP and the risk of COPD. The association between MSDP and TD was modeled using logistic regression, whereas the association with FTND scores was assessed using linear regression. The total effect of the initial variable on the outcome was defined as the sum of its direct and indirect effects. The indirect effect was further defined as the product of the initial variable’s impact on the intermediate variable and the intermediate variable’s impact on the outcome, with adjustments made for the initial variable. The statistical significance of the indirect effect was assessed through 1000 repetitions of a bootstrap procedure. Regarding the sensitivity analysis, we conducted a similar analysis by defining TD as a total FTND score ≥4. The sample size for this study was determined using the Monte Carlo method [25]. The details of the sample size calculation process are provided in Table S3 in Multimedia Appendix 1. All statistical analyses were conducted using R (version 4.2.1; R Foundation for Statistical Computing), with the use of packages such as bruceR, interactions, and mediation to estimate mediating effects. A significance level of P=.05 (2-tailed) was considered statistically significant.

Ethical Considerations

The study received approval from the ethics review committee of Beijing Capital Medical University (11-KE-42) and other collaborating institutes. Written informed consent was obtained from all study participants in accordance with the principles outlined in the Declaration of Helsinki. To ensure privacy and confidentiality, the data used in this study underwent anonymization and deidentification processes.


Participants

A total of 5943 participants were enrolled in this study, comprising 2991 individuals with COPD and 2952 matched controls. The demographic characteristics of all participants are elaborated in Table 1. In the control group, the mean age was 59.17 (SD 11.44) years, while in the COPD group, it was 59.50 (SD 11.66) years. Among controls, there were 1783 (60.40%) male participants, and in the COPD group, 1816 (60.70%) were male participants. Smoking was observed in 1442 (48.20%) individuals within the COPD group and 1412 (47.80%) individuals in the control group. For matching purposes, no statistically significant differences were detected between the 2 groups in terms of participants’ age, sex, and smoking. However, a higher proportion of mothers in the COPD group reported MSDP compared to the control group (COPD: n=305, 10.20% and controls: n=211, 7.10%; P<.001).

Table 1. Demographic characteristics of participants in this study.

Controls (n=2952)COPDa (n=2991)P value
Age (years), mean (SD)59.17 (11.44)59.50 (11.66).27b
Sex, n (%).82c

Female1169 (39.60)1175 (39.30)

Male1783 (60.40)1816 (60.70)
BMI (kg/m2), n (%)<.001c

<18.596 (3.30)129 (4.30)

18.5-251682 (57)1849 (61.80)

≥251174 (39.80)1013 (33.90)
Education, n (%)<.001c

Primary and below971 (32.90)1227 (41)

Junior middle school988 (33.50)987 (33)

Senior high school620 (21)493 (16.50)

Bachelor and above373 (12.60)284 (9.50)
Place of residence, n (%)<.001c

City1977 (67)1875 (62.7)

Countryside975 (33)1116 (37.3)
Nation, n (%).02c

Han Chinese2897 (98.10)2906 (97.20)

Other55 (1.90)85 (2.80)
Occupation, n (%)<.001c

Farmer794 (26.90)1172 (39.20)

Worker850 (28.80)678 (22.70)

Other1308 (44.30)1141 (38.10)
MSDPd, n (%)<.001c

No2741 (92.90)2686 (89.80)

Yes211 (7.10)305 (10.20)
Smoking, n (%).79c

No1540 (52.20)1549 (51.80)

Yes1412 (47.80)1442 (48.20)
GOLDe, n (%)f

11685 (56.30)

21103 (36.90)

3172 (5.80)

431 (1)
FEV1g, mean (SD)2.67 (0.66)2.13 (0.70)<.001b
FEV1/FVCh ratio, mean (SD)80.44 (5.63)61.18 (9.00)<.001b
AAHIi, mean (SD)1.34 (2.39)1.11 (1.18)<.001b
PM2.5j, mean (SD)71.85 (13.64)73.81 (15.95)<.001b
Childhood passive smoking, n (%).049c

No1184 (40.1)1276 (42.7)

Yes1768 (59.9)1715 (57.3)
History of childhood pneumonia or bronchitis, n (%)<.001c

No2842 (96.3)2789 (93.2)

Yes110 (3.7)202 (6.8)
Coronary heart disease, n (%).11c

No2888 (97.8)2906 (97.2)

Yes64 (2.2)85 (2.8)
Hypertension, n (%).007c

No2575 (87.2)2677 (89.5)

Yes377 (12.8)314 (10.5)
Diabetes, n (%).70c

No2851 (96.6)2895 (96.8)

Yes101 (3.4)96 (3.2)

aCOPD: chronic obstructive pulmonary disease.

bP value for 2-tailed t test.

cP value for chi-square test.

dMSDP: maternal smoking during pregnancy.

eGOLD: Global Initiative for Chronic Obstructive Lung Disease.

fNot available.

gFEV1: forced expiratory volume in 1 second.

hFVC: forced vital capacity.

iAAHI (average annual household income) is measured in 10,000 Yuan (a currency exchange rate of 1 Chinese Yuan (CNY)=US $0.16147 is applicable).

jPM2.5: fine particulate matter.

Differences of TD in Smokers Between the 2 Groups

As depicted in Table 2, the prevalence of TD was notably higher in the COPD group in comparison to the control group (COPD: n=582, 40.40%; controls: n=478, 33.90%; P=.001). Patients with COPD, when contrasted with the control group, exhibited a shorter time interval between waking up and the desire to smoke their first cigarette (Q1: P=.004) and encountered greater difficulty refraining from smoking in public places (Q2: P=.006). Among the COPD group, 19.40% (n=280) reported a tendency to smoke more frequently during the early hours after waking, whereas in the control group, this behavior was observed in 16.50% (n=233; P=.048). Additionally, the proportion of individuals smoking when unwell was higher in the COPD group than in the control group (Q6: P<.001). Q3 showed no statistically significant difference between the 2 groups, but with a P value <0.1, suggesting the potential presence of marginal effects.

Table 2. Differences between the COPDa and control group in the FTNDb among smokers.
QuestionsControls (n=1412), n (%)COPD (n=1442), n (%)P valuec
Q1d.004

After 60 minutes784 (55.50)728 (50.50)

31 to 60 minutes150 (10.60)132 (9.20)

6 to 30 minutes186 (13.20)235 (16.30)

Within 5 minutes292 (20.70)347 (24.10)
Q2e.006

No1122 (79.50)1082 (75)

Yes290 (20.50)360 (25)
Q3f.06

Any other1059 (75)1035 (71.80)

The first one in the morning353 (25)407 (28.20)
Q4g.62

10 or less1228 (87)1247 (86.50)

11 to 20141 (10)139 (9.60)

21 to 3019 (1.30)22 (1.50)

31 or more24 (1.70)34 (2.40)
Q5h.048

No1179 (83.50)1162 (80.60)

Yes233 (16.50)280 (19.40)
Q6i<.001

No1221 (86.50)1168 (81)

Yes191 (13.50)274 (19)
Total score1.92 (2.03)2.25 (2.14)<.001
TDj<.001

No934 (66.10)860 (59.60)

Yes478 (33.90)582 (40.40)

aCOPD: chronic obstructive pulmonary disease.

bFTND: Fagerstrom Test for Nicotine Dependence.

cP value for chi-square test.

dQ1: How soon after you wake up do you smoke your first cigarette?

eQ2: Do you find it difficult to refrain from smoking in places where it is forbidden?

fQ3: Which cigarette would you find most difficult to give up?

gQ4: How many cigarettes do you smoke per day?

hQ5: Do you smoke more frequently during the first hour after waking compared to the rest of the day?

iQ6: Do you smoke when you are so ill that you are confined to bed most of the day?

jTD: tobacco dependence.

Direct and Indirect Effects of MSDP on COPD in All Participants

The results of the mediation analysis for all participants are presented in Table 3. After adjusting for age, sex, BMI, educational attainment, place of residence, ethnicity, occupation, childhood passive smoking, residential PM2.5 exposure, history of childhood pneumonia or bronchitis, average annual household income, and medical history (coronary heart disease, hypertension, and diabetes), the total effect of MSDP on COPD was statistically significant (β=.097; P<.001). Furthermore, the direct effect of MSDP on COPD remained significant after adjusting for TD and other covariates (β=.094; P<.001). The indirect effect of TD was also found to be statistically significant (β=.004; P=.03). The sensitivity analysis revealed similar results (Table S4 in Multimedia Appendix 1).

Table 3. Mediating effect of TDa (mediating variable) on the association between MSDPb (independent variable) and COPDc (dependent variable) in all participantsd.
Pathβ (SE)P value
MSDP on COPDe.097 (0.023)<.001
MSDP on TDf.074 (0.017)<.001
TD on COPD given MSDPg.048 (0.018).007
Indirect: MSDP on COPDh.004 (0.002).03
Direct: MSDP on COPD given TDi.094 (0.023)<.001

aTD: tobacco dependence.

bMSDP: maternal smoking during pregnancy.

cCOPD: chronic obstructive pulmonary disease.

dAll analyses adjusted for age, sex, BMI, educational attainment, place of residence, ethnicity, occupation, childhood passive smoking, residential PM2.5 exposure, history of childhood pneumonia or bronchitis, average annual household income, and medical history (coronary heart disease, hypertension, and diabetes).

eTotal effect of independent variables on dependent variables.

fCoefficients of independent variables on mediating variables after adjustment for covariates.

gCoefficients of mediating variables on dependent variables after adjusted for covariates and IVs.

hIndirect effect of independent variables on dependent variables.

iDirect effect of independent variables on dependent variables.

Direct and Indirect Effects of MSDP on COPD in Smokers

The results of the mediation analysis for smokers are presented in Table 4. In this segment, all analyses were adjusted for age, sex, BMI, educational attainment, place of residence, ethnicity, occupation, childhood passive smoking, residential PM2.5 exposure, history of childhood pneumonia or bronchitis, average annual household income, and medical history (coronary heart disease, hypertension, and diabetes). Among smokers, both the total effect and direct effect (β) of MSDP on COPD were .123 and .120, respectively. Additionally, the indirect effect of TD was found to be statistically significant (β=.003; P=.03). The sensitivity analysis revealed similar results (Table S5 in Multimedia Appendix 1).

Table 4. Mediating effect of TDa (mediating variable) on the association between MSDPb (independent variable) and COPDc (dependent variable) in smokersd.
Pathβ (SE)P value
MSDP on COPDe.123 (0.032)<.001
MSDP on TDf.050 (0.031)<.001
TD on COPD given MSDPg.059 (0.019).004
Indirect: MSDP on COPDh.003 (0.002).03
Direct: MSDP on COPD given TDi.120 (0.031)<.001

aTD: tobacco dependence.

bMSDP: maternal smoking during pregnancy.

cCOPD: chronic obstructive pulmonary disease.

dAll analyses adjusted for age, sex, BMI, educational attainment, place of residence, ethnicity, occupation, childhood passive smoking, residential PM2.5 exposure, history of childhood pneumonia or bronchitis, average annual household income, and medical history (coronary heart disease, hypertension, and diabetes).

eCoefficients of independent variables on dependent variables after correction for covariates.

fCoefficients of independent variables on mediating variables after adjustment for covariates.

gCoefficients of mediating variables on dependent variables after correction for covariates and IVs.

hIndirect effect of independent variables on dependent variables.

iDirect effect of independent variables on dependent variables.


Principal Findings

The aim of this study was to investigate whether TD plays a role in the association between MSDP and COPD in offspring. A case-control study was conducted within the Chinese population. It was the first study to observe that MSDP has both a direct impact on COPD and an indirect influence mediated through TD. This mediation effect persists among the smoking population, and sensitivity analysis confirms the stability of these results.

It is well-established that smoking represents the primary risk factor for COPD, and an increasing body of evidence suggests that early life tobacco exposure plays a role in the onset and progression of COPD [26]. MSDP, as highlighted by Jaakkola et al [27], exerts substantial adverse effects on conditions such as asthma, chronic bronchitis, and chronic respiratory symptoms. Nevertheless, limited research has delved into the impact of prenatal tobacco smoke exposure on the development of COPD in later adulthood. This study, however, reveals an association between MSDP and the risk of COPD in offspring. Early life tobacco exposure has enduring consequences on lung function in offspring, with suboptimal intrauterine conditions leading to disturbances in lung development. As a result, affected individuals exhibit diminished lung function at birth, which often persists throughout their lifetime. This, in turn, elevates the risk of subsequent COPD, particularly in childhood wheeze disorders and genetically susceptible individuals [28]. To curb the current upward trend in COPD incidence, it is imperative to mitigate lung development risks by enhancing antenatal and neonatal care and reducing exposure to environmental pollutants, including passive tobacco smoke, both prenatally and postnatally.

In this study, MSDP emerges as a risk factor for TD in offspring, a finding consistent with prior research. Previous studies have established that individuals with a history of MSDP face an elevated risk of TD in adolescence and adulthood [18]. The precise mechanism underlying the connection between MSDP and offspring TD remains elusive. One plausible mechanism could involve the neurotoxic effects of harmful compounds present in tobacco smoke, which can readily traverse the placenta, potentially leading to smoking behavior and dependence in offspring [29]. Another conceivable mechanism is that MSDP is linked to preterm birth [30] and low birth weight [31], both of which could predispose offspring to various health challenges. Furthermore, it is essential for health care professionals to recognize that TD may be linked to early life tobacco exposure. Therefore, children exposed to MSDP should receive comprehensive education on topics such as diet, exercise, and smoking avoidance to mitigate their risk of developing COPD in adulthood.

This study revealed a direct association between TD and COPD. Previous research has identified smoking as one of the primary risk factors for COPD, causing inflammation and damage to the airways and lung tissue, ultimately leading to the development of COPD [32]. Recent studies have further suggested the correlation between TD and COPD [33]. Additionally, other studies suggest that TD may exacerbate the severity and progression of COPD [34]. Among individuals diagnosed with COPD, the presence of TD makes quitting smoking more challenging [35]. Thus, this study underscores the critical importance of addressing TD in the management and mitigation of COPD.

To our knowledge, we have discovered for the first time in this study that TD plays a mediating role in the association between MSDP and COPD. However, the specific reasons underlying this mediating mechanism remain unclear. There are several possible mechanisms to consider. First, genetic factors may be implicated, as MSDP has the potential to induce persistent epigenetic changes until adolescence [36]. These genetic alterations may contribute to the development of TD [37]. Consequently, TD can exacerbate challenges in smoking cessation and the progression of COPD [38]. Second, environmental factors may also be involved. Mothers who smoke during pregnancy may continue smoking during infancy, creating an early growth environment that promotes the risk of TD in offspring during lung development [39,40], subsequently leading to COPD. Our results highlight that TD serves as a partial mediator in the connection between MSDP and offspring COPD. Consequently, it becomes imperative to consider TD when addressing MSDP and smoking cessation efforts in offspring. Prior studies have advocated smoking cessation strategies for TD smokers, incorporating the use of medications such as varenicline, nicotine replacement therapy products, and bupropion [41]. Hence, clinicians should be cognizant of the necessity for appropriate smoking cessation interventions among individuals displaying signs of TD, ultimately contributing to the reduction of COPD risk.

Limitations

This study bears significant implications as it substantiates the partial mediating role of TD in the link between MSDP and COPD, underlining the importance of developing interventions targeting TD to mitigate the incidence of COPD in offspring. Nonetheless, it is essential to acknowledge the study’s limitations. First, the data concerning MSDP relied on questionnaire responses, introducing a potential source of recall bias. Due to the presence of recall bias, we cannot entirely rule out the possibility of uncertainty or erroneous memory in participants when reporting maternal smoking behavior during pregnancy. To enhance the accuracy of capturing MSDP information, future studies may consider using prospective cohort designs. Second, the absence of genetic data represents a significant limitation in this study. Despite the inclusion of various participant covariates, the intricate role of genetic factors in influencing COPD was not considered due to data constraints. Future research endeavors could overcome this limitation by integrating comprehensive genetic analyses into the study design. Finally, our classification of nonsmokers as nonnicotine-dependent during the overall analysis might introduce some bias. To fortify the robustness of our findings, we conducted a parallel subgroup analysis among the smoking population that consistently demonstrated the robustness of our results.

Conclusions

MSDP exerts an adverse influence on the risk of COPD in offspring, and TD plays a partially mediating role in this association. These findings underscore the potential for clinicians to mitigate the impact of MSDP on COPD in offspring by addressing TD. Consequently, early intervention strategies aimed at reducing TD become imperative in the endeavor to mitigate the risk of COPD.

Acknowledgments

The authors thank the participants of the China Pulmonary Health study. For continuous support, assistance, and cooperation, the authors thank Xinran Zhang and Xiaoying Gu (China-Japan Friendship Hospital); Ping Li, Mengyu Cheng, Wen Han, Hu Liu, Pengfei Wang, Jing Li, and Jing Wu (Shanxi Bethune Hospital Shanxi Academy of Medical Sciences); Yang Li and Ting Liu (First Affiliated Hospital of Xi’an Jiaotong University); Liekou Ma (Fufeng People’s Hospital); Luoping Yuan (Luonan Hospital); Jianbo Liu (Jingyang Hospital); Hubin Xi (Shanyang People’s Hospital); Baoping Wu (Changning Township Hospital of Wugong); Zhifang Liu (Meixian People’s Hospital); Cheng Zhang, Hong Yu, Weijia Liu, Ruiming Wu, Li Zhao, Yankun Jin, Lu Zhang, Mengning Zhen, Ping Lu, and Ling Li (Guizhou Provincial People’s Hospital); Bin Wu and Weimin Yao (Affiliated Hospital of Guangdong Medical University); Yanjie Yang, Li Manning, Qi Chen, Ying Gong, Mingfei Zhang, and Sulan Wei (Shanghai Zhongshan Hospital); Zhihua Chen, Gang Huang, Niya Zhou, Bin Shen, Wen Hua, Bin Zhang, Youlian Yu, and Juan Xiong (Second Affiliated Hospital of Zhejiang University); Ting Yang, Yongchun Shen, Diandian Li, Hongyu Long, Zenglin Liao, Xiaoou Li, Yanqiu Wu, Xiang Tong, Xiaying Peng, Bo Wang, Zhixin Qiu, Jian Luo, Lanlan Zhang, Shuang Zhao, Xingyu Xiong, Yinyin Yang, Yalun Li, Yanqqi He, Faming Jiang, Ting Wang, Jiajia Dong, Jing An, Linwei Li, Lian Liu, and Yonggang Zhang (West China Hospital); Liuqun Jia (First Affiliated Hospital of Zhengzhou University); Caishuang Pang (Chongqing Cancer Hospital); Qianjing Hu (People’s Hospital of Yubei District of Chonqing); Shujin Guo and Xiaying Peng (Sichuan Province People’s Hospital); Min Li (First Affiliated Hospital of Kunming Medical University); Lingli Guo (North China University of Science and Technology); Xue Zhang (Luoyang Orthopedic Hospital of Henan Province); Wen Du (West China Teaching Hospital); Yinyin Yang (Chengdu Second People’s Hospital); Lin Li (Mianyang Central Hospital); Jingyu Quan, Baosen Pang, Min Zhu, Xiaohong Chang, Jun Zhang, Baomei Wu, Ping Xin, Xiuxia Huang, Zhiyuan An, Shuilian Chu, Qiuyun Liu, Yanrui Jia, Jie Xia, Ying Cui, Jing Zhao, Chunyan Zhang, Jingyu Yang, and Xu Wu (Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital); Ruiyan Lin, Jie Song, Zhenyang Xu, and Xiaohui Li (Beijing Luhe Hospital); Rui Wu, Yanling Ding, Ming Lu, Jing Zhang, Lina Sun, Chengcheng Liao, Yun Sun, Yixuan Liao, Fan Lin, Yu Bai, and Meng Wang (Peking University Third Hospital); Lei Wang and Rong Gao (Beixiaguan Primary Care Center); Lingbo Sun and Xiaoliang Xie (Peking University Health Science Center Primary Care Center); and Pengjun Zhang, Hongsheng Zhang, Di Chai, and Xiaomeng Li (Beijing Hospital). The study was funded by the Chinese Academy of Medical Sciences (CAMS) Initiative for Innovative Medicine (CAMS 2021-I2M-1-010) and the Special Research Foundation for Public Welfare of Health, Ministry of Health of China (grant 201002008).

Data Availability

The data sets generated and analyzed during this study are available from the corresponding author on reasonable request.

Authors' Contributions

JL, DX, KH, TY, JX, LY, J Zhao, Xiangyan Zhang, CB, JK, PR, HS, FW, YC, TS, GS, Y Lin, GH, SW, J Zhu, JH, and CW conceived and designed the study. CW supervised the study. JL did the statistical analysis. All authors contributed to data collection and interpretation. JL, DX, and CW drafted the report. All authors revised the report and approved the final version before submission.

Conflicts of Interest

None declared.

Multimedia Appendix 1

Supplementary tables.

DOCX File , 24 KB

  1. Varmaghani M, Dehghani M, Heidari E, Sharifi F, Moghaddam SS, Farzadfar F. Global prevalence of chronic obstructive pulmonary disease: systematic review and meta-analysis. East Mediterr Health J. 2019;25 (1):47-57. [FREE Full text] [CrossRef] [Medline]
  2. Adeloye D, Song P, Zhu Y, Campbell H, Sheikh A, Rudan I, et al. NIHR RESPIRE Global Respiratory Health Unit. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. Lancet Respir Med. 2022;10 (5):447-458. [FREE Full text] [CrossRef] [Medline]
  3. Wang C, Xu J, Yang L, Xu Y, Zhang X, Bai C, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet. 2018;391 (10131):1706-1717. [CrossRef] [Medline]
  4. Silverman EK. Genetics of COPD. Annu Rev Physiol. 2020;82:413-431. [FREE Full text] [CrossRef] [Medline]
  5. Niu Y, Zhou Y, Chen R, Yin P, Meng X, Wang W, et al. Long-term exposure to ozone and cardiovascular mortality in China: a nationwide cohort study. Lancet Planet Health. 2022;6 (6):e496-e503. [FREE Full text] [CrossRef] [Medline]
  6. Wheaton AG, Liu Y, Croft JB, VanFrank B, Croxton TL, Punturieri A, et al. Chronic obstructive pulmonary disease and smoking status—United States, 2017. MMWR Morb Mortal Wkly Rep. 2019;68 (24):533-538. [FREE Full text] [CrossRef] [Medline]
  7. Sin DD. The importance of early chronic obstructive pulmonary disease: a lecture from 2022 Asian Pacific Society of respirology. Tuberc Respir Dis (Seoul). 2023;86 (2):71-81. [FREE Full text] [CrossRef] [Medline]
  8. Chu X, Ye J, Wen Y, Li P, Cheng B, Cheng S, et al. Maternal smoking during pregnancy and risks to depression and anxiety in offspring: an observational study and genome-wide gene-environment interaction analysis in UK biobank cohort. J Psychiatr Res. 2021;140:149-158. [CrossRef] [Medline]
  9. Liu L, Cheng S, Wen Y, Jia Y, Cheng B, Meng P, et al. Maternal smoking around birth may lower the protective effects of breastfeeding on anxiety, depression and neuroticism in adult offspring: a UK biobank study. Eur Arch Psychiatry Clin Neurosci. 2023;273 (2):481-492. [CrossRef] [Medline]
  10. Ayubi E, Safiri S, Mansori K. Association between maternal smoking during pregnancy and risk of bone fractures in offspring: a systematic review and meta-analysis. Clin Exp Pediatr. 2021;64 (3):96-102. [FREE Full text] [CrossRef] [Medline]
  11. Duan P, Wang Y, Lin R, Zeng Y, Chen C, Yang L, et al. Impact of early life exposures on COPD in adulthood: a systematic review and meta-analysis. Respirology. 2021;26 (12):1131-1151. [FREE Full text] [CrossRef] [Medline]
  12. Hajdusianek W, Żórawik A, Waliszewska-Prosół M, Poręba R, Gać P. Tobacco and nervous system development and function—new findings 2015-2020. Brain Sci. 2021;11 (6):797. [FREE Full text] [CrossRef] [Medline]
  13. Gómez-Roig MD, Pascal R, Cahuana MJ, García-Algar O, Sebastiani G, Andreu-Fernández V, et al. Environmental exposure during pregnancy: influence on prenatal development and early life: a comprehensive review. Fetal Diagn Ther. 2021;48 (4):245-257. [CrossRef] [Medline]
  14. Xiao D, Wang C. Tobacco dependence should be recognised as a lethal non-communicable disease. BMJ. 2019;365:l2204. [CrossRef] [Medline]
  15. Zhu J, Nelson K, Toth J, Muscat JE. Nicotine dependence as an independent risk factor for atherosclerosis in the National Lung Screening Trial. BMC Public Health. 2019;19 (1):103. [FREE Full text] [CrossRef] [Medline]
  16. Hsieh MT, Tseng PT, Wu YC, Tu YK, Wu HC, Hsu CW, et al. Effects of different pharmacologic smoking cessation treatments on body weight changes and success rates in patients with nicotine dependence: a network meta-analysis. Obes Rev. 2019;20 (6):895-905. [CrossRef] [Medline]
  17. Pérez-Rubio G, Córdoba-Lanús E, Cupertino P, Cartujano-Barrera F, Campos MA, Falfán-Valencia R. Role of genetic susceptibility in nicotine addiction and chronic obstructive pulmonary disease. Rev Invest Clin. 2019;71 (1):36-54. [FREE Full text] [CrossRef] [Medline]
  18. Duko B, Pereira G, Tait RJ, Nyadanu SD, Betts K, Alati R. Prenatal tobacco exposure and the risk of tobacco smoking and dependence in offspring: a systematic review and meta-analysis. Drug Alcohol Depend. 2021;227:108993. [CrossRef] [Medline]
  19. Huang K, Yang T, Xu J, Yang L, Zhao J, Zhang X, et al. Prevalence, risk factors, and management of asthma in China: a national cross-sectional study. Lancet. 2019;394 (10196):407-418. [FREE Full text] [CrossRef] [Medline]
  20. Niu Y, Yang T, Gu X, Chen R, Meng X, Xu J, et al. Long-term ozone exposure and small airway dysfunction: the China Pulmonary Health (CPH) study. Am J Respir Crit Care Med. 2022;205 (4):450-458. [FREE Full text] [CrossRef] [Medline]
  21. Liu Z, Li YH, Cui ZY, Li L, Nie XQ, Yu CD, et al. Prevalence of tobacco dependence and associated factors in China: findings from nationwide China Health Literacy Survey during 2018-19. Lancet Reg Health West Pac. 2022;24:100464. [FREE Full text] [CrossRef] [Medline]
  22. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict. 1991;86 (9):1119-1127. [CrossRef] [Medline]
  23. Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am J Respir Crit Care Med. 2017;195 (5):557-582. [FREE Full text] [CrossRef] [Medline]
  24. Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986;51 (6):1173-1182. [CrossRef] [Medline]
  25. Schoemann AM, Boulton AJ, Short SD. Determining power and sample size for simple and complex mediation models. Soc Psychol Pers Sci. 2017;8 (4):379-386. [CrossRef]
  26. Savran O, Ulrik CS. Early life insults as determinants of chronic obstructive pulmonary disease in adult life. Int J Chron Obstruct Pulmon Dis. 2018;13:683-693. [FREE Full text] [CrossRef] [Medline]
  27. Jaakkola JJK, Kosheleva AA, Katsnelson BA, Kuzmin SV, Privalova LI, Spengler JD. Prenatal and postnatal tobacco smoke exposure and respiratory health in Russian children. Respir Res. 2006;7 (1):48. [FREE Full text] [CrossRef] [Medline]
  28. Stocks J, Sonnappa S. Early life influences on the development of chronic obstructive pulmonary disease. Ther Adv Respir Dis. 2013;7 (3):161-173. [FREE Full text] [CrossRef] [Medline]
  29. Hyman SE. Addiction: a disease of learning and memory. Am J Psychiatry. 2005;162 (8):1414-1422. [FREE Full text] [CrossRef] [Medline]
  30. Soneji S, Beltrán-Sánchez H. Association of maternal cigarette smoking and smoking cessation with preterm birth. JAMA Netw Open. 2019;2 (4):e192514. [FREE Full text] [CrossRef] [Medline]
  31. Di HK, Gan Y, Lu K, Wang C, Zhu Y, Meng X, et al. Maternal smoking status during pregnancy and low birth weight in offspring: systematic review and meta-analysis of 55 cohort studies published from 1986 to 2020. World J Pediatr. 2022;18 (3):176-185. [CrossRef] [Medline]
  32. Hikichi M, Mizumura K, Maruoka S, Gon Y. Pathogenesis of chronic obstructive pulmonary disease (COPD) induced by cigarette smoke. J Thorac Dis. 2019;11 (Suppl 17):S2129-S2140. [FREE Full text] [CrossRef] [Medline]
  33. Galiatsatos P, Kaplan B, Lansey DG, Ellison-Barnes A. Tobacco use and tobacco dependence management. Clin Chest Med. 2023;44 (3):479-488. [CrossRef] [Medline]
  34. Tashkin DP. Smoking cessation in COPD: confronting the challenge. Intern Emerg Med. 2021;16 (3):545-547. [FREE Full text] [CrossRef] [Medline]
  35. Montes de Oca M, Laucho-Contreras ME. Smoking cessation and vaccination. Eur Respir Rev. 2023;32 (167):220187. [FREE Full text] [CrossRef] [Medline]
  36. Rauschert S, Melton PE, Burdge G, Craig JM, Godfrey KM, Holbrook JD, et al. Maternal smoking during pregnancy induces persistent epigenetic changes into adolescence, independent of postnatal smoke exposure and is associated with cardiometabolic risk. Front Genet. 2019;10:770. [FREE Full text] [CrossRef] [Medline]
  37. Hutchison KE, Allen DL, Filbey FM, Jepson C, Lerman C, Benowitz NL, et al. CHRNA4 and tobacco dependence: from gene regulation to treatment outcome. Arch Gen Psychiatry. 2007;64 (9):1078-1086. [FREE Full text] [CrossRef] [Medline]
  38. Falomir-Pichastor JM, Blondé J, Desrichard O, Felder M, Riedo G, Folly L. Tobacco dependence and smoking cessation: the mediating role of smoker and ex-smoker self-concepts. Addict Behav. 2020;102:106200. [CrossRef] [Medline]
  39. Huggett SB, Keyes M, Iacono WG, McGue M, Corley RP, Hewitt JK, et al. Age of initiation and transition times to tobacco dependence: early onset and rapid escalated use increase risk for dependence severity. Drug Alcohol Depend. 2019;202:104-110. [CrossRef] [Medline]
  40. Rydell M, Cnattingius S, Granath F, Magnusson C, Galanti MR. Prenatal exposure to tobacco and future nicotine dependence: population-based cohort study. Br J Psychiatry. 2012;200 (3):202-209. [FREE Full text] [CrossRef] [Medline]
  41. Rigotti NA, Kruse GR, Livingstone-Banks J, Hartmann-Boyce J. Treatment of tobacco smoking: a review. JAMA. 2022;327 (6):566-577. [CrossRef] [Medline]


COPD: chronic obstructive pulmonary disease
CPH: China Pulmonary Health
FEV1: forced expiratory volume in 1 second
FTND: Fagerstrom Test for Nicotine Dependence
FVC: forced vital capacity
MSDP: maternal smoking during pregnancy
PM2.5: fine particulate matter
TD: tobacco dependence


Edited by A Mavragani, T Sanchez; submitted 28.09.23; peer-reviewed by X Qi, K Zhang, Y Yang, H Guo, Y Fan; comments to author 09.11.23; revised version received 29.11.23; accepted 07.01.24; published 22.02.24.

Copyright

©Jinxuan Li, Jianying Xu, Lan Yang, Yongjian Xu, Xiangyan Zhang, Chunxue Bai, Jian Kang, Pixin Ran, Huahao Shen, Fuqiang Wen, Kewu Huang, Wanzhen Yao, Tieying Sun, Guangliang Shan, Ting Yang, Yingxiang Lin, Jianguo Zhu, Ruiying Wang, Zhihong Shi, Jianping Zhao, Xianwei Ye, Yuanlin Song, Qiuyue Wang, Gang Hou, Yumin Zhou, Wen Li, Liren Ding, Hao Wang, Yahong Chen, Yanfei Guo, Fei Xiao, Yong Lu, Xiaoxia Peng, Biao Zhang, Zuomin Wang, Hong Zhang, Xiaoning Bu, Xiaolei Zhang, Li An, Shu Zhang, Zhixin Cao, Qingyuan Zhan, Yuanhua Yang, Lirong Liang, Bin Cao, Huaping Dai, Kian Fan Chung, Zhengming Chen, Jiang He, Sinan Wu, Dan Xiao, Chen Wang, China Pulmonary Health Study Group. Originally published in JMIR Public Health and Surveillance (https://publichealth.jmir.org), 22.02.2024.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Public Health and Surveillance, is properly cited. The complete bibliographic information, a link to the original publication on https://publichealth.jmir.org, as well as this copyright and license information must be included.